Physician profile
Edrick E Lopez
NPI 1346556784
$10,451.33
in general payments reported to CMS, 2019-2025
34 companies · $580 in 2025
The $580 reported for 2025 was more than what 81% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,628 · 2020: $1,004 · 2021: $1,964 · 2022: $1,084 · 2023: $678 · 2024: $514 · 2025: $580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,771.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,190.40 | 2019-2023 | Proclaim, Octrode |
| Nevro Corp. | $2,509.47 | 2019-2024 | Senza |
| Medtronic USA, INC. | $1,290.65 | 2019-2020 | |
| Medtronic, INC. | $349.19 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Relievant Medsystems, INC. | $158.15 | 2022 | |
| Janssen Pharmaceuticals, INC | $149.15 | 2019-2023 | Xarelto |
| Si-Bone, INC. | $147.30 | 2023-2025 | |
| Boston Scientific Corporation | $140.75 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Forte Bio-Pharma LLC | $131.60 | 2021 | |
| Novo Nordisk INC | $110.48 | 2023 | |
| Scilex Pharmaceuticals INC. | $110.06 | 2019-2023 | Ztlido |
| Bayer Healthcare Pharmaceuticals INC. | $107.86 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $105.45 | 2019 | |
| Saluda Medical Americas, INC. | $100.96 | 2025 | Evoke |
| Biotronik Nro, INC. | $92.67 | 2024-2025 | Prospera |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $92.04 | 2023-2025 | Gelsyn-3 |
| Lundbeck LLC | $88.60 | 2022-2025 | Vyepti |
| Spinal Simplicity, LLC | $79.35 | 2024-2025 | Ha Minuteman G3-R |
| Pfizer INC. | $67.91 | 2023-2025 | |
| Globus Medical, INC. | $43.20 | 2025 | Senza |
| Allergan, INC. | $42.50 | 2019-2022 | |
| Nalu Medical, INC. | $41.31 | 2025 | Nalu Neurostimulation System |
| Abbvie INC. | $38.84 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $35.15 | 2019 | |
| Azurity Pharmaceuticals, INC. | $32.90 | 2023 | Horizant |
| Assertio Therapeutics, INC. | $31.49 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $27.50 | 2025 | |
| Biodelivery Sciences International, INC. | $23.53 | 2019 | |
| Valinor Pharma, LLC | $22.36 | 2023 | Movantik |
| Depuy Synthes Sales INC. | $19.85 | 2024 | Monovisc, Orthovisc |
| Spr Therapeutics, INC | $19.05 | 2019 | |
| Collegium Pharmaceutical, INC. | $18.77 | 2024 | Belbuca |
| Mdd US Operations, LLC | $18.29 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.55 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edrick Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.